1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ADAPTIMMUNE THERAPEUTICS PLC - ADR
Adaptimmune Therapeutics Plc - ADR XNAS: ADAP

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Adaptimmune Therapeutics PLC (ADR) is on 19 Jan 2026 for the purpose of Adaptimmune Therapeutics PLC Third Quarter Earnings Result for 2025 See details

Adaptimmune Therapeutics PLC (ADR) - ADAP - stock price prediction, stock price target, analyst ratings from 3 analysts

Adaptimmune Therapeutics PLC (ADR) has a share price target of US$ 1, revenue growth forecast of -77.3%, and profit growth estimate of -31.3% for FY25, based on top 3 analyst calls.

Forecaster Screeners